Hide Message

Updating the Resource Centre Digital Platform

The Business & Human Rights Resource Centre is at a critical point in its development. Our digital platform is home to a wealth of information on business and human rights, but hasn’t had a visual refresh for a number of years.

We will soon be updating the site to improve its usability and better serve the thousands of people that use our site to support their work.

Please take an advance peek at our new look, and let us know what you think!

Thank you,
Alex Guy, Digital Officer

Find Out More Hide Message

Barack Obama visit may pressurise govt to dilute patent laws, fears medical body

Author: PB Jayakumar, Business Today, Published on: 21 January 2015

US President Barack Obama's visit to India is likely to accelerate ongoing pressure from the US on the Indian government to dilute its patent laws to help multinational drug makers, fears international medical humanitarian organisation Medecins Sans Frontieres/Doctors Without Borders (MSF)...The US multinational lobby is pressurising the Indian Government to dilute rules related to Section 3 (d) of Indian Patent Act on incremental innovations and Section 84 related to compulsory licensing (allowing generic companies to make drugs despite the patent) during emergencies.

Read the full post here